Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease Who Have Normal Calprotectin Levels

Anke Heida; Gea A. Holtman; Yvonne Lisman-van Leeuwen; Marjolein Y. Berger; Patrick F. van Rheenen

doi:10.1097/MPG.0000000000000939

Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease Who Have Normal Calprotectin Levels

Anke Heida^*, Gea A. Holtman, Yvonne Lisman-van Leeuwen, Marjolein Y. Berger, Patrick F. van Rheenen

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

Abstract

In children with suspected inflammatory bowel disease, adding calprotectin stool testing to the screening strategy has been recommended to distinguish organic from nonorganic disease. In this cohort study with historical controls, we could not confirm that screening with stool calprotectin improves the diagnostic yield (ratio inflammatory bowel disease-positive endoscopies and total number of endoscopies); however, in patients with normal fecal calprotectin levels (

Original language	English
Pages (from-to)	47-49
Number of pages	3
Journal	Journal of Pediatric Gastroenterology and Nutrition
Volume	62
Issue number	1
DOIs	https://doi.org/10.1097/MPG.0000000000000939
Publication status	Published - Jan-2016

Keywords

calprotectin
diagnostic yield
inflammatory bowel disease
S100A8/A9
FECAL CALPROTECTIN
METAANALYSIS

Access to Document

10.1097/MPG.0000000000000939

Handle.net

Persistent link

Embargoed Document

Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease
Final publisher's version, 100 KB
Request copy

Cite this

@article{ad38a99208cd4741934bd6d64719927a,

title = "Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease Who Have Normal Calprotectin Levels",

abstract = "In children with suspected inflammatory bowel disease, adding calprotectin stool testing to the screening strategy has been recommended to distinguish organic from nonorganic disease. In this cohort study with historical controls, we could not confirm that screening with stool calprotectin improves the diagnostic yield (ratio inflammatory bowel disease-positive endoscopies and total number of endoscopies); however, in patients with normal fecal calprotectin levels (",

keywords = "calprotectin, diagnostic yield, inflammatory bowel disease, S100A8/A9, FECAL CALPROTECTIN, METAANALYSIS",

author = "Anke Heida and Holtman, {Gea A.} and {Lisman-van Leeuwen}, Yvonne and Berger, {Marjolein Y.} and {van Rheenen}, {Patrick F.}",

year = "2016",

month = jan,

doi = "10.1097/MPG.0000000000000939",

language = "English",

volume = "62",

pages = "47--49",

journal = "Journal of Pediatric Gastroenterology and Nutrition",

issn = "0277-2116",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease Who Have Normal Calprotectin Levels

AU - Heida, Anke

AU - Holtman, Gea A.

AU - Lisman-van Leeuwen, Yvonne

AU - Berger, Marjolein Y.

AU - van Rheenen, Patrick F.

PY - 2016/1

Y1 - 2016/1

N2 - In children with suspected inflammatory bowel disease, adding calprotectin stool testing to the screening strategy has been recommended to distinguish organic from nonorganic disease. In this cohort study with historical controls, we could not confirm that screening with stool calprotectin improves the diagnostic yield (ratio inflammatory bowel disease-positive endoscopies and total number of endoscopies); however, in patients with normal fecal calprotectin levels (

AB - In children with suspected inflammatory bowel disease, adding calprotectin stool testing to the screening strategy has been recommended to distinguish organic from nonorganic disease. In this cohort study with historical controls, we could not confirm that screening with stool calprotectin improves the diagnostic yield (ratio inflammatory bowel disease-positive endoscopies and total number of endoscopies); however, in patients with normal fecal calprotectin levels (

KW - calprotectin

KW - diagnostic yield

KW - inflammatory bowel disease

KW - S100A8/A9

KW - FECAL CALPROTECTIN

KW - METAANALYSIS

U2 - 10.1097/MPG.0000000000000939

DO - 10.1097/MPG.0000000000000939

M3 - Article

C2 - 26252922

VL - 62

SP - 47

EP - 49

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 1

ER -